IPSC: Century Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

Info & Links

CEO

Brent Pfeiffenberger

Headquarters

25 N 38th Street, 11th Floor
PHILADELPHIA, PA 19104, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

128

Employees

150

Century Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

45.92M

Enterprise Value

-5.94M

Enterprise Value/EBITDA(ttm)

0.25

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.41

Price to Book(mrq)

0.20

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-19.10%

Profit Margin(ttm)

-2197.43%

Return on Equity(ttm)

-10.71%

Return on Invested Capital(ttm)

-20.52%

Return on Assets(ttm)

-5.96%

Income Statement

Revenue(ttm)

114.90M

Revenue Per Share(ttm)

1.33

Gross Profit(ttm)

114.90M

EBITDA(ttm)³

-23.90M

Net Income Available to Common(ttm)

-21.94M

Diluted EPS(ttm)

-0.29

Share Statistics

Beta (5Y Monthly)

1.78

52-Week Change

-76.28%

S&P 500 52-Week Change

16.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

86.16M

Dividend Yield

0.00%

Float⁴

81.85M

% Held by Insiders

5.00%

% Held by Institutions

50.20%

Balance Sheet

Total Cash(mrq)

165.12M

Total Cash Per Share(mrq)

1.92

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.70%

Quick Ratio(mrq)

11.70%

Book Value Per Share(mrq)

2.79

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.40

Free Cash Flow(ytd)

-35.10M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

IPSC

Century Therapeutics, Inc. Common Stock

Century Therapeutics, Inc. Common Stock Profile